DNA/RNA heteroduplex oligonucleotide technology for regulating lymphocytes in vivo

Abstract

Using gene silencing to regulate lymphocyte function is a promising therapeutic approach for autommunity, inflammation and cancer. Here the authors use a heteroduplex oligonucleotide for improved potency, efficacy and longer retention times.